(Q37669320)

21 August 2017

title

The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer (English)

1 reference

21 August 2017

1 reference

1 reference

1 reference

2

Stacey A Missmer

1 reference

21 August 2017

5

Ann H Partridge

1 reference

21 August 2017

Mary E Abusief

1

1 reference

21 August 2017

Elizabeth S Ginsburg

series ordinal

3

1 reference

21 August 2017

Jane C Weeks

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

21 August 2017

1 reference

21 August 2017

volume

116

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

791-798

1 reference

21 August 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Risk of menopause during the first year after breast cancer diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Life after breast cancer: understanding women's health-related quality of life and sexual functioning

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Web-based survey of fertility issues in young women with breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Adjuvant docetaxel for node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24835

7 January 2021

Identifiers

DOI

10.1002/CNCR.24835

1 reference

release_4lbja3lhonbrldqyetk4t7c6fy

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4lbja3lhonbrldqyetk4t7c6fy

24 November 2022

mapped directly with Wikidata item

1 reference